Wendelien Zeijlemaker

DR.

20122019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

  • 9 Article
  • 2 Chapter
  • 2 Meeting Abstract
  • 1 Research VU University Amsterdam, graduation VU University Amsterdam

CD34+CD38 leukemic stem cell frequency to predict outcome in acute myeloid leukemia

Zeijlemaker, W., Grob, T., Meijer, R., Hanekamp, D., Kelder, A., Carbaat-Ham, J. C., Oussoren-Brockhoff, Y. J. M., Snel, A. N., Veldhuizen, D., Scholten, W. J., Maertens, J., Breems, D. A., Pabst, T., Manz, M. G., van der Velden, V. H. J., Slomp, J., Preijers, F., Cloos, J., van de Loosdrecht, A. A., Löwenberg, B. & 4 othersValk, P. J. M., Jongen-Lavrencic, M., Ossenkoppele, G. J. & Schuurhuis, G. J., 1 May 2019, In : Leukemia. 33, 5, p. 1102-1112 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia

Zeijlemaker, W., Kelder, A., Cloos, J. & Schuurhuis, G. J., 1 Dec 2019, In : Current Protocols in Cytometry. 91, 1, e66.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

The interference of genetic associations in establishing the prognostic value of the immunophenotype in acute myeloid leukemia

van Solinge, T. S., Zeijlemaker, W., Ossenkoppele, G. J., Cloos, J. & Schuurhuis, G. J., 1 Jan 2018, In : Cytometry Part B. Clinical Cytometry. 94, 1, p. 151-158 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

GRAFT VERSUS LEUKEMIA EFFECT OF ALLOGENEIC STEM CELL TRANSPLANTATION AND MINIMAL RESIDUAL DISEASE IN PATIENTS WITH AML IN FIRST COMPLETE REMISSION

Versluis, J., Kalin, B., Zeijlemaker, W., Passweg, J., Graux, C., Manz, M., Vekemans, M-C., Biemond, B., Legdeur, M-C., Kooy, M. V. M., Janssen, J., Pabst, T., Lowenberg, B., Jongen-Lavrencic, M., Schuurhuis, G. J., Ossenkoppele, G. & Cornelissen, J., 26 Jun 2017, In : Haematologica. 102, p. 7-7

Research output: Contribution to journalMeeting AbstractAcademic

LEUKEMIC STEM CELL FREQUENCY COMBINED WITH MRD IS AN IMPORTANT BIOMARKER TO PREDICT RELAPSE IN ACUTE MYELOID LEUKEMIA. RESULTS FROM A PROSPECTIVE H102 STUDY

Zeijlemaker, W., Meijer, R., Kelder, A., Carbaat-Ham, J., Oussoren-brockhoff, Y., Snel, S., Veldhuizen, D., Scholten, W., Maertens, J., Breems, D., Pabst, T., Manz, M., Van der Velden, V., Slomp, J., Valk, P., Cloos, J., Lowenberg, B., Ossenkoppele, G. & Schuurhuis, G. J., 26 Jun 2017, In : Haematologica. 102, p. 7-8

Research output: Contribution to journalMeeting AbstractAcademic